Treatment News : Leptin Reduces Belly Fat

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » April 2009

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


April 9, 2009

Leptin Reduces Belly Fat

HIV-positive men who were given an experimental version of the hormone leptin had a significant reduction in their belly fat after three months of treatment, according to a study published in the April issue of The Journal of Clinical Endocrinology & Metabolism.

Leptin helps the body regulate appetite and how it uses fat stores for energy. Both human and animal studies have found that abnormally low leptin levels can lead to unhealthy changes in cholesterol, triglycerides and insulin.

To determine whether increasing leptin levels using a manufactured version of the hormone might help normalize cholesterol, triglyceride and insulin levels, Kathleen Mulligan, PhD, from the University of California in San Francisco, and her colleagues enrolled eight HIV-positive men with low leptin levels. All of the men had triglyceride and low-density lipoprotein (LDL)—the bad cholesterol—levels that were too high. The men also had insulin resistance, which can ultimately lead to diabetes, belly fat accumulation and lipoatrophy. The men received twice daily injections of leptin, with doses based on their body weight.

Mulligan’s team found that leptin replacement significantly reduced LDL and triglyceride levels. It also increased the levels of high-density lipoprotein (HDL)—the good cholesterol—and lowered the men’s degree of insulin resistance.

Of particular note, leptin also decreased the men’s belly fat accumulation by 32 percent, without further decreasing fat in the limbs. This reduction exceeds decreases reported with other experimental therapies. For example, Serono’s growth hormone (Serostim) decreased belly fat accumulation by 21 to 24 percent, and its growth hormone promoter tesamorelin, expected to be approved later this year, decreases belly fat by 15 percent. Plus, Mulligan’s team reports, leptin improved the body’s ability to break down blood glucose, whereas tesamorelin does not.

The authors caution that this is a very small pilot study and that the treatment was not compared with a placebo, which will be critical to proving its efficacy and safety. Nevertheless, the results are sufficiently impressive, and further studies are being urged.

Search: leptin, hormone, fat metabolism, lipoatrophy, fat accumulation, diabetes, blood sugar, glucose, HDL, LDL, cholesterol, triglycerides, Kathleen Mulligan, belly, gut

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (5 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.